Product Information
QUETIAPINE ER 400 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.3226 per EA under NDC 16729009712. Its NADAC has been published 488 times since Jan 18, 2017.
FDA first approved this application on Nov 1, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the QUETIAPINE FUMARATE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
400 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729009712
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA090681FDA Approved
11/1/2016
TE Code
AB
On Market Since
11/1/2016
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE ER 400 MG TABLET has been published 488 times since Jan 18, 2017, and over the history we have for it it has declined 98.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3226 per EA |
|---|---|
| All-time high | $19.9187 (Feb 15, 2017) |
| All-time low | $0.2506 (Jul 17, 2024) |
| 52-week high | $0.3390 |
| 52-week low | $0.3021 |
| Median price | $0.5008 |
| Average price | $1.5429 |
| Largest weekly change | -82.7% (Jul 19, 2017) |
| Weeks tracked | 488 |
| Tracking since | Jan 18, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
-4.8%
1Y
+5.6%
3Y
-32.2%
5Y
-39.2%
All
-98.4%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the QUETIAPINE FUMARATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUETIAPINE ER 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE ER 400 MG TABLET, manufactured by Accord Healthcare Inc., is $0.3226 per EA (NDC 16729009712), effective May 20, 2026.
How has the price of QUETIAPINE ER 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUETIAPINE ER 400 MG TABLET has declined 98.4%. It has been tracked across 488 weekly CMS publications since Jan 18, 2017.
What are the highest and lowest recorded NADAC prices for QUETIAPINE ER 400 MG TABLET?
Since Jan 18, 2017, the NADAC for QUETIAPINE ER 400 MG TABLET has ranged from a low of $0.2506 (Jul 17, 2024) to a high of $19.9187 (Feb 15, 2017), with a median of $0.5008 per EA.
Are there cheaper alternatives to QUETIAPINE ER 400 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of QUETIAPINE ER 400 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QUETIAPINE ER 400 MG TABLET?
QUETIAPINE ER 400 MG TABLET (NDC 16729009712) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.